REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $714,434 | +70.6% | 7,007 | +52.1% | 0.04% | +46.2% |
| Q1 2023 | $418,778 | +64.2% | 4,606 | +81.9% | 0.03% | +188.9% |
| Q3 2021 | $255,000 | -34.8% | 2,532 | -8.4% | 0.01% | -30.8% |
| Q2 2021 | $391,000 | +73.0% | 2,763 | +51.4% | 0.01% | +30.0% |
| Q4 2020 | $226,000 | -26.1% | 1,825 | -6.9% | 0.01% | -41.2% |
| Q2 2020 | $306,000 | +1.7% | 1,960 | -6.1% | 0.02% | -26.1% |
| Q1 2020 | $301,000 | -36.2% | 2,087 | -9.6% | 0.02% | +9.5% |
| Q4 2019 | $472,000 | +60.5% | 2,308 | -35.7% | 0.02% | +90.9% |
| Q3 2018 | $294,000 | – | 3,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $94,902,000 | 15.92% |
| Opaleye Management Inc. | 407,002 | $13,333,000 | 4.14% |
| Ikarian Capital, LLC | 649,600 | $21,281,000 | 2.80% |
| AWH Capital, L.P. | 150,000 | $2,459,457 | 2.54% |
| Boxer Capital, LLC | 1,239,000 | $40,590,000 | 2.09% |
| EcoR1 Capital, LLC | 1,975,611 | $64,721,000 | 2.02% |
| Camber Capital Management LP | 1,500,000 | $49,140,000 | 1.78% |
| MPM BioImpact LLC | 180,000 | $5,897,000 | 1.58% |
| Sofinnova Investments, Inc. | 602,545 | $19,739,000 | 1.50% |
| KRS Capital Management, LLC | 28,141 | $921,000 | 1.00% |